With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

If the last couple years have taught us one thing about managing money, it's that having some savings set aside is crucial. Despite the significance of having savings, however, research shows that 45% ...